ICL Group Ltd Expands Portfolio and Enhances Market Position
ICL Group Ltd (Tel Aviv Stock Exchange: ICL) announced a definitive agreement to acquire Bartek Ingredients, a global leader in food‑grade malic and fumaric acid. The transaction, completed on 18 December 2025, is expected to broaden ICL’s specialty food solutions offering and strengthen its presence in the food ingredient market.
The acquisition aligns with ICL’s strategy to diversify beyond its core chemical and fertilizer businesses. Bartek’s product portfolio is utilized across a range of applications in the food industry, providing ICL with new revenue streams and complementary technology.
In addition to the Bartek deal, ICL has been actively promoting innovative solutions for its core fertilizer business. On 16 December 2025, the company’s Ferti‑Tour platform showcased cutting‑edge technology that helps European farmers improve fertilizer efficiency, sustainability, and on‑farm performance. The demonstration underscored ICL’s commitment to sustainability and to delivering value to agricultural stakeholders.
Leadership changes also occurred during the period. On 18 December 2025, the former President and Chief Executive Officer of ICL Group, Raviv Zoller, was appointed Chairman of the Board at TopGum, indicating a shift in ICL’s executive structure.
Financially, ICL’s share price closed at 1,614 ILA on 17 December 2025, within a 52‑week range of 1,573–2,558 ILA. The company’s market capitalization stood at approximately 6.38 billion ILA, and its price‑earnings ratio was 17.37. These figures reflect a stable valuation for a company with diversified operations in chemicals, fertilizers, and specialty food ingredients.
The combined impact of the Bartek acquisition, the Ferti‑Tour innovation showcase, and executive realignment positions ICL Group Ltd for continued growth in both its traditional and emerging markets.
